BIOANALYTICAL SYS INC's ticker is BASI and the CUSIP is 09058M103. A total of 18 filers reported holding BIOANALYTICAL SYS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ESSEX INVESTMENT MANAGEMENT CO LLC | 95,872 | $481,000 | 0.08% |
| Versant Capital Management, Inc | 19,191 | $97,000 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 67,510 | $343,000 | 0.01% |
| NORTH STAR ASSET MANAGEMENT INC | 10,000 | $50,000 | 0.00% |
| Renaissance Technologies | 503,406 | $2,525,000 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 63,849 | $321,000 | 0.00% |
| tru Independence LLC | 1,100 | $6,000 | 0.00% |
| VANGUARD GROUP INC | 449,627 | $2,255,000 | 0.00% |
| UBS Group AG | 13,660 | $69,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |